It suggests that RT enhances CD8+ T cell recognition of tumors that may be due to CXCL9/10-mediated recruitment of T lymphocytes [23, 37] since we demonstrated that RT also induced CXCL9/10 expression in tumor cells (Fig. 1A). This evidence concerns the gene CD8A and neoplasm.